Bench to Bedside: Platelet-rich Plasma—How Do We Adequately “Untranslate” Translational “Breakthroughs” in an After-market Setting?-Reference-Cited by-同舟云学术

Bench to Bedside: Platelet-rich Plasma—How Do We Adequately “Untranslate” Translational “Breakthroughs” in an After-market Setting?

Published:2016-10 Issue:10 Volume:474 Page:2104-2107
ISSN:0009-921X
Container-title:Clinical Orthopaedics & Related Research
language:en
Short-container-title:

Author:

Potter Benjamin K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Orthopedics and Sports Medicine,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s11999-016-4992-z.pdf

Reference3 articles.

1. Union rates using autologous platelet concentrate alone and with bone graft in high-risk foot and ankle surgery patients.;Bibbo;J Surg Orthop Adv,2005

2. Platelet-rich plasma in orthopaedic applications: Evidence-based recommendations for treatment.;Hsu;J Am Acad Orthop Surg,2013

3. Platelet-rich therapies for musculoskeletal soft tissue injuries.;Moraes;Conchrane Database Syst Rev,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Bench to Bedside: Detangling Safety and Efficacy for Products and Interventions That May Be Neither;Clinical Orthopaedics & Related Research;2022-06-21

2. Regenerative Plasma- und Zelltherapien in der Orthopädie und Unfallchirurgie;OP-JOURNAL;2022-03-09

3. Platelet‐rich plasma and regenerative dentistry;Australian Dental Journal;2020-03-24

4. On Patient Safety: Regenerative Medicine—The Hype Amplifies Safety Concerns;Clinical Orthopaedics & Related Research;2019-05-30

5. CORR Insights®: Prolotherapy Induces an Inflammatory Response in Human Tenocytes In Vitro;Clinical Orthopaedics & Related Research;2017-08